Clinical Trial Update: Effects of Caffeine on Intermittent Hypoxia in Infants Born Preterm [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effect of caffeine citrate on intermittent hypoxia in preterm infants; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apnea of Prematurity

Drugs mentioned

• Caffeine citrate (caffeine citrate)

Snippet

Sponsor: American SIDS Institute | Conditions: Hypoxia | Phase 3 | Status: COMPLETED | Results posted: 2015-03-17